Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Washington Roundup, March 2013

Executive Summary

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.”

You may also be interested in...



Pioneer ACOs Raise Concerns About Meeting Quality Measures

The ACOs say they should only be held to reporting data to CMS on the quality measures tied to the program this year, rather than be expected to necessarily meet the set quality thresholds, citing lack of evidence.

Companies Dig Into Sunshine Rule Details In Preparation For Aug. 1 Go-Live Date

CMS has finalized several sunshine rule provisions: the definition of “applicable manufacturer” has been narrowed; many payments to speakers at continuing medical education programs and events need not be reported; and the agency will allow manufacturers to supply contextual information on the public database.

CMS Touts Growth Of Accountable Care Organization Program

The Medicare agency has 154 provider organizations participating in shared savings programs and has received letters of intent from another 400 who may join next January. One provider details ways its use of medical technology may change as it moves to accountable care.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel